<SEC-DOCUMENT>0001104659-16-156969-index.html : 20161114
<SEC-HEADER>0001104659-16-156969.hdr.sgml : 20161111
<ACCEPTANCE-DATETIME>20161114171751
ACCESSION NUMBER:		0001104659-16-156969
CONFORMED SUBMISSION TYPE:	NT 10-Q
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20160930
FILED AS OF DATE:		20161114
DATE AS OF CHANGE:		20161114
EFFECTIVENESS DATE:		20161114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OSIRIS THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001360886
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				710881115
		STATE OF INCORPORATION:			MD
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		NT 10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32966
		FILM NUMBER:		161995941

	BUSINESS ADDRESS:	
		STREET 1:		7015 ALBERT EINSTEIN DRIVE
		CITY:			COLUMBIA
		STATE:			MD
		ZIP:			21046
		BUSINESS PHONE:		443-545-1819

	MAIL ADDRESS:	
		STREET 1:		7015 ALBERT EINSTEIN DRIVE
		CITY:			COLUMBIA
		STATE:			MD
		ZIP:			21046
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>a16-21622_1nt10q.htm
<DESCRIPTION>NT 10-Q
<TEXT>
Document 1 - file: a16-21622_1nt10q.htm

</DOCUMENT>
</SEC-DOCUMENT>